ARHGEF18

UniProt ID: Q6ZSZ5
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

ARHGEF18, also called p114RhoGEF and septin-associated RhoGEF (SA-RhoGEF), is a Dbl-family guanine nucleotide exchange factor built around a DH catalytic domain (residues 447-644) followed by a PH domain (684-786), preceded by a degenerate C2H2 zinc finger and followed by a long coiled coil and disordered C-terminus. Purified protein catalyses nucleotide exchange on RhoA and binds RhoA but not Rac1 or Cdc42; in cells it has also been reported to activate Rac1, and no source finds activity on Cdc42. Its defining property is not which GTPase it acts on but where. It is recruited to the apical junctional complex of epithelia and to endothelial tight junctions, where it generates a spatially restricted pool of active RhoA that drives ROCK-dependent myosin II light-chain phosphorylation, assembles the circumferential actomyosin belt, and matures tight junctions into a functional permeability barrier. Recruitment is combinatorial and tissue-specific, through the junctional adaptors cingulin and paracingulin (with ZO-1 upstream in endothelium), the FERM proteins EPB41L4B/Lulu2 and EPB41L5, the polarity proteins PATJ and CRB3A, and LKB1. Its activity is modulated by heterotrimeric G proteins. G beta-gamma subunits stimulate its exchange activity, and a region near its own C-terminus binds G alpha 12 but not G alpha 13, through an interface distinct from the RH domain that the RH-RhoGEFs use. It is also bound by SEPTIN9, which inhibits it in one setting and activates it in others. Activated RhoA binds back onto the PH domain, a positive-feedback interface resolved at 1.4 angstrom. Loss of the protein does not simply abolish Rho signalling. Junctional RhoA falls while non-junctional RhoA rises, so depleted cells lose their junctional actomyosin belt and gain basal stress fibres at the same time. The same module operates in retinal neuroepithelium, kidney podocytes, syncytiotrophoblast, eosinophils and endothelium under shear stress, and the Drosophila ortholog Cysts performs the equivalent role at fly adherens junctions. Biallelic loss-of-function variants cause autosomal-recessive adult-onset retinal degeneration (retinitis pigmentosa 78).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005085 guanyl-nucleotide exchange factor activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic propagation of exchange-factor activity from PANTHER node PTN002677784, seeded by the Drosophila ortholog cyst/Dp114RhoGEF, mouse Arhgef2, human AKAP13, ARHGEF28 and ARHGEF2, and the target itself. This is the core molecular function, and it is independently established by direct biochemistry on the purified human protein.
Reason: Every WITH/FROM token was resolved against its own authority. FB:FBgn0032796 is Drosophila cyst/CG10188, also called Dp114RhoGEF; MGI:MGI:103264 is mouse Arhgef2; Q12802 is AKAP13/Lbc; Q8N1W1 is ARHGEF28/p190RhoGEF; Q92974 is ARHGEF2/GEF-H1. The fly gene is a genuine ortholog rather than a distant paralog, which is what makes this a legitimate deep node. Silver et al. call Cysts the Drosophila orthologue of mammalian p114RhoGEF, GEF-H1, p190RhoGEF and AKAP-13, so PTN002677784 sits ancestral to the whole Lbc clade before its vertebrate expansion. One observation is worth registering rather than repairing. Current PANTHER assigns human Q6ZSZ5 and mouse Q6P9R4 to PTHR47440:SF1, while every other seed in this list, the fly ortholog included, now sits in PTHR13944. The family label on the annotation no longer matches the family labels on its seeds, which is a consequence of PANTHER splitting the vertebrate ARHGEF18 lineage into its own family after the IBD was made, not evidence that the seeds are wrong. The propagation is in any case redundant here, because human ARHGEF18 carries an IDA for the same term and Blomquist et al. measured exchange on purified protein. The catalytic Dbl tyrosine is intact at Tyr-606, which is supporting rather than decisive; see the residue claim and the knowledge gap on substrate identity.
Propagation Review
Root cause: NO FAILURE CORE
Sources checked:
PANTHER:PTN002677784 · PTHR47440 ancestral node, Lbc/RH-RhoGEF clade SUPPORTS TRANSFER
Node predates the vertebrate expansion of the Lbc clade; current PANTHER places the seeds across two families, PTHR47440 and PTHR13944.
FB:FBgn0032796 · Drosophila cyst / CG10188 / Dp114RhoGEF SUPPORTS TRANSFER
The single fly ortholog of ARHGEF18, GEF-H1, ARHGEF28 and AKAP13. Independently annotated GO:0005085 by IDA from PMID:36917931. UniProt entries Q9VIV0, M9PBE1 and Q8MQR4, all PANTHER PTHR13944:SF21.
MGI:MGI:103264 · mouse Arhgef2 (GEF-H1) SUPPORTS TRANSFER
Resolves to UniProtKB:Q60875, ARHG2_MOUSE, PANTHER PTHR13944:SF20.
UniProtKB:Q12802 · AKAP13 (Lbc) SUPPORTS TRANSFER
PANTHER PTHR13944:SF18.
UniProtKB:Q8N1W1 · ARHGEF28 (p190RhoGEF) SUPPORTS TRANSFER
PANTHER PTHR13944:SF22.
UniProtKB:Q92974 · ARHGEF2 (GEF-H1) SUPPORTS TRANSFER
PANTHER PTHR13944:SF20.
UniProtKB:Q6ZSZ5 · human ARHGEF18, the target itself SUPPORTS TRANSFER
The target's own accession, which is expected rather than circular. ARHGEF18 carries GO:0005085 by IDA from PMID:14512443, and that annotation is one of the descendant evidences the PAINT curator used to place the IBD, so the gene legitimately appears among the sources of the IBA it later receives. Its presence marks experimental grounding on the target; what the IBA then adds is that the activity is inherited from the ancestral Lbc clade rather than being lineage-specific.
Supporting Evidence:
PMID:11085924
p114-Rho-GEF interacted specifically with RhoA, in its nucleotide-free and guanosine 5'-[gamma-thio]triphosphate-bound states, but not with Rac1 and Cdc42, and efficiently catalysed guanine nucleotide exchange of RhoA
PMID:31409654
To explore the regulation of Rho GTPases in vivo, we analyzed the Rho GTPase guanine nucleotide exchange factor (RhoGEF) Cysts, the Drosophila orthologue of mammalian p114RhoGEF, GEF-H1, p190RhoGEF, and AKAP-13
file:human/ARHGEF18/ARHGEF18-bioinformatics/RESULTS.md
Bottom line: Tyr-606 is conserved in all 14 panel members including the Rac- and Cdc42-specific GEFs, so retaining it says the DH domain is of the catalytically competent type and says nothing whatever about which GTPase ARHGEF18 acts on.
GO:0005085 guanyl-nucleotide exchange factor activity
IDA
PMID:14512443
G Protein betagamma subunits stimulate p114RhoGEF, a guanine...
ACCEPT
Summary: Direct assay of exchange-factor activity. Niu et al. used pull-downs and dominant-negative GTPases in cells and found activation of RhoA and Rac1 but not Cdc42; Blomquist et al. had already shown exchange on purified RhoA. This is the gene's core molecular function and its only curated molecular-function evidence.
Reason: The term is correct and is the most specific one GO offers. It is worth being explicit that this is not a granularity choice. GO:0005089 Rho guanyl-nucleotide exchange factor activity was merged into GO:0005085 (obsolete, term replaced by GO:0005085, obsolescence reason IAO:0000227), as were the Rac, Ras, ARF, Rab and Ran equivalents, and GO:0005085 now has no is_a children. Checked in QuickGO, OLS4 and the GO API, because QuickGO silently resolves merges and returns the replacement record as non-obsolete. Substrate identity is therefore carried in core_functions.substrates and recorded as an ontology knowledge gap rather than proposed as a new term. Two caveats on the evidence itself, both left in place rather than acted on. First, this paper's Rac1 result is contradicted by the purified-protein experiment in PMID:11085924 and by the in-cell depletion in PMID:21258369; UniProt carries both readings and so does this review. Second, Reactome places ARHGEF18 in a generic GEFs catalyst set for a p75NTR reaction whose stated outputs are RAC1 and Cdc42, which is a set-level assignment rather than a measurement on this protein.
Supporting Evidence:
PMID:14512443
we have determined that p114RhoGEF activated RhoA and Rac1 but not Cdc42 proteins
PMID:11085924
p114-Rho-GEF interacted specifically with RhoA, in its nucleotide-free and guanosine 5'-[gamma-thio]triphosphate-bound states, but not with Rac1 and Cdc42, and efficiently catalysed guanine nucleotide exchange of RhoA
PMID:21258369
p114RhoGEF is a widely expressed gene and, in vitro, functions as a specific activator of RhoA17-19. Accordingly, depletion of p114RhoGEF resulted in reduced levels of active RhoA in HCE cells without significantly affecting Rac and Cdc42
file:human/ARHGEF18/ARHGEF18-deep-research-affinage.md
Through its DH/PH catalytic module it activates RhoA (and Rac1, but not Cdc42)
Knowledge gap:
Whether ARHGEF18 is a RhoA-only exchange factor or acts on Rac1 as well is unresolved, and the answer is not expressible in GO either way. OPEN BIOLOGYONTOLOGY MF_DARK
Resolve: Biologically, real-time exchange kinetics on the human DH-PH module against a RhoA, Rac1, Cdc42, RhoB and RhoC panel would settle it. The one systematic Dbl-family panel of this kind does not include p114RhoGEF. Ontologically nothing can be proposed, since GO:0005089, GO:0030676, GO:0005088, GO:0005086, GO:0017112 and GO:0005087 were all merged into GO:0005085, which now has zero is_a children in both OLS4 and QuickGO, exactly as the RhoGAP terms were merged into GO:0005096.
GO:0005085 guanyl-nucleotide exchange factor activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic assignment from the DH domain signature (IPR000219) and the ARHGEF18-specific PH signature (IPR037744). Correct and fully redundant with the IDA and IBA rows for the same term.
Reason: The domain assignment it rests on is real and matches UniProt's own feature table, which places the DH domain at 447-644 and the PH domain at 684-786. The IPR037744 signature is ARHGEF18-specific rather than generic, so this is not a family-wide over-call. It adds nothing the IDA does not already carry.
GO:0005515 protein binding
IPI
PMID:25753039
ZO-1 controls endothelial adherens junctions, cell-cell tens...
KEEP AS NON CORE
Summary: Co-immunoprecipitation with CGNL1 (paracingulin, called JACOP in the paper) from human dermal microvascular endothelial cell extracts. The interaction is real and mechanistically important, but protein binding as a term says nothing about what it does.
Reason: Q0VF96 resolves to CGNL1, cingulin-like protein 1. The finding this row stands for is that paracingulin, downstream of ZO-1, is what puts ARHGEF18 at endothelial junctions, which is the recruitment arm of the protein's core function rather than an accessory contact. Kept rather than removed because the interaction is directly observed; non-core because the informative content is a localisation dependency and GO:0005515 cannot express it. The same paper's two IMP rows do carry that content. A more informative molecular-function term is not available, since GO:0017048 Rho GTPase binding, the nearest analogue for the partner class, was itself merged into GO:0031267 small GTPase binding, and that would in any case be the wrong partner here.
Supporting Evidence:
PMID:25753039
p114RhoGEF and JACOP coimmunoprecipitated from endothelial cell extracts, and both ZO-1 and JACOP were required for junctional recruitment of p114RhoGEF
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
KEEP AS NON CORE
Summary: Interaction with AKAP13 detected by endogenous tagging in the OpenCell high-throughput interactome, curated by IntAct. Q12802 is AKAP13/Lbc, a paralogous RhoGEF of the same Lbc clade.
Reason: A single high-throughput pull-down between two members of the same RhoGEF clade, with no follow-up anywhere in the literature and no functional consequence reported. Kept because the dataset is a curated interactome rather than a prediction and the accession resolves correctly; non-core because nothing is known about what the contact does, and because paralogs sharing a compartment are a well-known source of proximity-tagging signal. Worth noting for the future that AKAP13 is also one of the PAINT seeds for this gene's exchange-factor IBD, so the two proteins are linked both phylogenetically and physically without either link being explained.
GO:0005737 cytoplasm
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: Mapped from UniProt's Cytoplasm subcellular-location statement, which is attributed to PMID:15558029, where endogenous SA-RhoGEF colocalises with Sept9b along actin stress fibres in REF52 fibroblasts.
Reason: True but uninformative. A cytoplasmic pool is expected for a protein that cycles onto junctions, and Terry et al. describe exactly that, an antibody staining both the junctional complex and a cytoplasmic pool. The functionally meaningful locations are the apical plasma membrane and the junctional complex.
GO:0005829 cytosol
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: Human Protein Atlas immunofluorescence. Consistent with the diffuse cytoplasmic pool seen by antibody staining in epithelial cells.
Reason: An antibody-based localisation in cultured cells that are not necessarily forming mature junctions will report the soluble pool, which is where the protein waits rather than where it acts. Kept because it is a direct observation; non-core for the same reason the cytoplasm row is non-core.
GO:0005829 cytosol
TAS
Reactome:R-HSA-205039
KEEP AS NON CORE
Summary: One of two Reactome cytosol rows. This one comes from the reaction p75NTR indirectly activates RAC and Cdc42 via a guanyl-nucleotide exchange factor, in which ARHGEF18 is a member of a generic GEFs catalyst set rather than a named participant.
Reason: Querying the Reactome content service confirms both the participation and its nature. ARHGEF18 is returned among the reaction's reference entities, and the catalyst is guanyl-nucleotide exchange factor activity of GEFs, a set. The reaction's declared input and output are RAC1 bound to GDP and RAC1 bound to GTP, and its display name additionally invokes Cdc42, a GTPase that both primary papers agree ARHGEF18 does not act on. The compartment assignment is therefore inherited from set membership, not measured on this protein. Kept rather than removed because a cytosolic pool is independently real, and because the Rac1 half of the reaction is not contradicted by PMID:14512443. Marked non-core, and the Cdc42 over-reach is recorded here rather than acted on, since the annotation under review is a localisation.
Propagation Review
Root cause: SOURCE WEAK OR INFERRED
Failure modes: ROLE CONFLATION
Sources checked:
Reactome:R-HSA-205039 · p75NTR indirectly activates RAC and Cdc42 via a guanyl-nucleotide exchange factor SOURCE WEAK OR INFERRED
ARHGEF18 enters this reaction as an unnamed member of a generic GEFs catalyst set; the compartment is a participant-compartment assignment, and the reaction name invokes Cdc42, which ARHGEF18 does not act on.
GO:0005829 cytosol
TAS
Reactome:R-HSA-419166
KEEP AS NON CORE
Summary: The second Reactome cytosol row, from the reaction GEFs activate RhoA,B,C. ARHGEF18 is again a member of a generic GEFs catalyst set, but here the reaction substrate matches the protein's established activity.
Reason: Same mechanism as the other Reactome cytosol row, and the same verdict, but this reaction is the biologically apt one. Its input and output are RhoA, RhoB and RhoC bound to GDP and to GTP, which is what this protein is documented to do. The compartment is still a set-level participant assignment rather than an observation, so it stays non-core.
GO:0005856 cytoskeleton
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: Mapped from UniProt's Cytoplasm, cytoskeleton statement, attributed to PMID:15558029, where SA-RhoGEF and Sept9b colocalise along actin stress fibres in REF52 cells and SA-RhoGEF fragments alter endogenous septin filament structures.
Reason: Supported by the cited experiment, but the observation is in fibroblasts, not in the junction-forming epithelia where this protein's characterised function lies, and stress-fibre association there is the phenotype the protein suppresses once junctions form. Kept because the underlying immunofluorescence is real; non-core because cytoskeleton is a very general compartment and the association is indirect, mediated by septins.
Supporting Evidence:
PMID:15558029
We have identified a Rho-guanine nucleotide exchange factor (GEF) as a binding partner for a mammalian septin Sept9b using yeast two-hybrid screening
GO:0005886 plasma membrane
EXP
PMID:29601110
Expression of novel "LOCGEF" isoforms of ARHGEF18 in eosinop...
KEEP AS NON CORE
Summary: Turton et al. show that the LOCGEF isoforms of ARHGEF18 expressed in human eosinophils are distributed perimembranously in resting cells and relocate to the tip of the nucleopod on activation.
Reason: A genuine experimental localisation in a primary human cell type, and the only one outside epithelium and endothelium. Non-core because plasma membrane is the general parent of the functionally informative location, which is the apical plasma membrane and the junctional complex; and because this experiment concerns isoforms 1 to 3, which carry alternative N-termini, while the p114 isoform is not detected in eosinophils, so it is not obvious that the junctional mechanism applies there.
Supporting Evidence:
PMID:29601110
Immunofluorescence microscopy revealed striking relocalization of LOCGEFs from the plasma membrane to the two poles upon polarization of eosinophils by IL5, IL33 and CCL11
PMID:29601110
No p114 transcript or protein band was detected in eosinophils.
GO:0005886 plasma membrane
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic propagation of plasma-membrane localisation from PANTHER node PTN002677825, restricted to taxon 117571. Both seeds are human ARHGEF18.
Reason: Both seeds are the gene being annotated. UniProtKB:Q6ZSZ5 is the reviewed human ARHGEF18 entry and UniProtKB:A0A590UK10 is a 1089-residue unreviewed entry for the same human gene, assigned to the same PANTHER subfamily PTHR47440:SF1. That is expected rather than circular, because ARHGEF18 carries this compartment experimentally, by EXP from PMID:29601110 and by IDA from the Human Protein Atlas, and such descendant evidence is exactly what a PAINT curator uses to place an ancestral call. What follows is only that the row adds no evidence the target did not already have. Kept rather than removed because the conclusion is correct and is_active_in is arguably the better qualifier for a GEF that must be membrane proximal to load its substrate; non-core because the term is the general parent of apical plasma membrane. Worth recording for the family rather than for this row: the node is restricted to taxon 117571 and no non-human member has yet contributed to it, so the inheritance claim it encodes is currently untested outside human.
Propagation Review
Root cause: EVIDENCE CIRCULAR OR REDUNDANT
Sources checked:
PANTHER:PTN002677825 · PTHR47440 node restricted to taxon 117571 (Euteleostomi) SUPPORTS TRANSFER
Node placement rests on the target's own experimental localisation; no non-human member of the clade has contributed evidence to it yet.
UniProtKB:Q6ZSZ5 · human ARHGEF18, reviewed entry, the target itself SUPPORTS TRANSFER
Carries GO:0005886 by EXP from PMID:29601110 and by IDA from GO_REF:0000052. Self-appearance marks experimental grounding on the target.
UniProtKB:A0A590UK10 · human ARHGEF18, unreviewed 1089-residue entry for the same gene SUPPORTS TRANSFER
Resolved against UniProt. Gene name ARHGEF18, organism Homo sapiens, PANTHER PTHR47440:SF1. The same gene as the target under a second accession, so it is not an independent ortholog.
GO:0005886 plasma membrane
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: Human Protein Atlas immunofluorescence placing the protein at the plasma membrane, consistent with the EXP row and with junctional staining in epithelia.
Reason: Direct and consistent with three independent lines of evidence, but at the general parent of the informative term. The functionally meaningful statement is the apical plasma membrane and the apical junction complex, both of which are covered separately.
GO:0005886 plasma membrane
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: Mapped from UniProt's Cell membrane statement, attributed to PMID:29601110. The fourth row for this term.
Reason: Correct and redundant with the EXP row derived from the same publication. Non-core for the same reason as the other plasma-membrane rows.
GO:0070160 tight junction
IDA
PMID:21258369
Spatially restricted activation of RhoA signalling at epithe...
NEW
Summary: Proposed new annotation. Terry et al. image endogenous p114RhoGEF against tight-junction and adherens-junction markers in Caco-2 and human corneal epithelial cells and find it overlapping occludin but not E-cadherin.
Reason: The most specific compartment this gene has direct evidence for, and it is absent from GOA entirely. The marker comparison is the informative part, because overlapping occludin and not E-cadherin distinguishes the tight junction from the adherens junction rather than placing the protein at junctions in general. It is corroborated in a second tissue by Tornavaca et al., where ZO-1 and paracingulin are both required to recruit the protein to endothelial junctions. GOA currently records only GO:0030054 cell junction, six times over, from Reactome complex membership. The parent term is deliberate. GO:0005923 bicellular tight junction is the legacy term most existing annotations sit on, but it asserts a subtype this experiment cannot resolve, since confocal colocalisation along a junctional belt does not separate bicellular from tricellular contacts. Occludin is not a marker that excludes tricellular contacts either, though the point is weaker than it first looks and is stated here at the strength the source supports. PMID:40878853 finds occludin in close proximity to tricellulin at cell-cell junctions and shows that occludin knockout perturbs tricellulin localisation at tricellular tight junctions, while also reporting that occludin itself does not accumulate at them as prominently as tricellulin does. So occludin is predominantly bicellular but is present and functionally required at tricellular contacts, which makes it unable to license the subtype on its own. The resolution argument is the load-bearing one and stands without this. Choosing the parent also makes the companion GO:0043296 annotation non-redundant, because GO:0005923 has GO:0043296 among its parents in both OLS4 and QuickGO while GO:0070160 does not, so located_in would have propagated one from the other.
Supporting Evidence:
PMID:21258369
Junctional p114RhoGEF overlapped with occludin, a tight junction protein, but not E-cadherin, an adherens junction component, indicating that p114RhoGEF associates with the apical junctional complex and tight junctions
PMID:40878853
BioID proteomics identified several proximity partners of tricellulin, and knockout studies on angulin-1/LSR, occludin and afadin provided evidence that these proteins control tricellulin accumulation to tTJs to different extents and mechanisms.
PMID:40878853
tricellulin is in close proximity to occludin and afadin at cell-cell junctions, but neither one of these other proteins displays similar prominent accumulation to tTJs as tricellulin
GO:0007264 small GTPase-mediated signal transduction
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic propagation from PTN002677784 with the target itself as the only seed.
Reason: The sole gene seed is UniProtKB:Q6ZSZ5, the gene being annotated, and that is expected rather than circular. ARHGEF18 carries GO:0007264 by IDA from PMID:14512443, and a PAINT curator placing an ancestral call uses exactly such descendant evidence, so the target legitimately appears among the sources of the IBA it receives. A short donor list is likewise not weak support. What follows is only that the row adds no evidence the target did not already have, which is a reason to treat it as non-core rather than as a defect. Non-core also because the term is one of the broadest in the process ontology, and because the informative content, that the small GTPase is RhoA, is what GO cannot express.
Propagation Review
Root cause: EVIDENCE CIRCULAR OR REDUNDANT
Sources checked:
PANTHER:PTN002677784 · PTHR47440 ancestral node, Lbc/RH-RhoGEF clade SUPPORTS TRANSFER
The same node carries a well-seeded GO:0005085 IBD across six accessions, so the node placement itself is multi-species; for this term the curator cited the target's own experimental annotation.
UniProtKB:Q6ZSZ5 · human ARHGEF18, the target itself and the sole gene seed SUPPORTS TRANSFER
Carries GO:0007264 by IDA from PMID:14512443. Self-appearance in the WITH/FROM marks experimental grounding on the target and is not circularity.
GO:0007264 small GTPase-mediated signal transduction
IDA
PMID:14512443
G Protein betagamma subunits stimulate p114RhoGEF, a guanine...
KEEP AS NON CORE
Summary: Direct evidence that expressing p114RhoGEF changes the GTP-loading state of Rho-family GTPases in cells, from the same experiments that support the exchange-factor IDA.
Reason: Correct but at the top of the process branch. The specific content of the experiment is RhoA and Rac1 loading, and the informative process term for a GEF is the positive-regulation one, GO:0035025, which this review proposes on the IBA row for GO:0035023. The acts_upstream_of_or_within qualifier is appropriate for a readout measured on the downstream GTPase rather than on the GEF.
Supporting Evidence:
PMID:14512443
we have determined that p114RhoGEF activated RhoA and Rac1 but not Cdc42 proteins
GO:0007264 small GTPase-mediated signal transduction
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: InterPro2GO mapping from IPR037744, the ARHGEF18-specific PH-domain signature.
Reason: The signature is specific to this protein family rather than a generic PH match, so the mapping is sound. Redundant with the IDA and IBA rows for the same term, and equally general.
GO:0008360 regulation of cell shape
IDA
PMID:14512443
G Protein betagamma subunits stimulate p114RhoGEF, a guanine...
KEEP AS NON CORE
Summary: Expressing p114RhoGEF induces cell rounding and stress-fibre formation, which Niu et al. used as the functional readout of RhoA activation.
Reason: A real gain-of-function phenotype, reproduced independently in J82 and HEK-293 cells by Blomquist et al. Non-core because it is a downstream consequence of RhoA activation in a sparse overexpression setting rather than a physiological role, and because the same protein produces the opposite cortical phenotype in a junction-forming monolayer. Cell shape is also where the disease and tissue biology converges without being the molecular function, since the apical constriction, actomyosin belt and lumen phenotypes are all shape changes downstream of the same exchange activity.
Supporting Evidence:
PMID:11085924
the overexpression of p114-Rho-GEF in J82 and HEK-293 cells induced the formation of actin stress fibres and stimulated serum-response-factor-mediated gene transcription in a Rho-dependent manner
GO:0016324 apical plasma membrane
EXP
PMID:22006950
Lulu2 regulates the circumferential actomyosin tensile syste...
ACCEPT
Summary: Nakajima and Tanoue localise p114RhoGEF to apical cell-cell boundaries in epithelial cells, where Patj recruits it through a PDZ-mediated interaction and Lulu2 activates it.
Reason: This is the functionally informative location and the one the mechanism requires. It is corroborated by three independent groups. Terry et al. report that junctional p114RhoGEF overlaps with occludin but not E-cadherin, placing it at the apical junctional complex rather than the adherens junction; Tornavaca et al. show that ZO-1 and paracingulin are both required for junctional recruitment in endothelium; and the medaka mutant loses apicobasal polarity of the retinal neuroepithelium. Kept at core level because localisation here is not incidental, it is the substrate of the protein's defining property, which is spatially restricted RhoA activation.
Supporting Evidence:
PMID:22006950
We further found that Patj, an apical cell polarity regulator, recruits p114RhoGEF to apical cell-cell boundaries via PDZ (PSD-95/Dlg/ZO-1) domain-mediated interaction
PMID:21258369
Junctional p114RhoGEF overlapped with occludin, a tight junction protein, but not E-cadherin, an adherens junction component, indicating that p114RhoGEF associates with the apical junctional complex and tight junctions
GO:0016324 apical plasma membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Mapped from UniProt's Apical cell membrane statement, which is attributed to the same publication as the EXP row.
Reason: Correct, and redundant with the EXP row it derives from. Accepted rather than demoted because the term itself is the functionally informative one.
GO:0030036 actin cytoskeleton organization
IDA
PMID:14512443
G Protein betagamma subunits stimulate p114RhoGEF, a guanine...
KEEP AS NON CORE
Summary: Stress-fibre induction on p114RhoGEF expression, the actin arm of the same gain-of-function experiment behind the cell-shape row.
Reason: True, and true for essentially every RhoA GEF, which is what makes it uninformative at this level. The specific and reproducible statement about this protein is that it builds the junctional actomyosin belt and, in doing so, suppresses basal stress fibres; that content sits in the GO:0051497 and GO:0150105 rows and in core_functions. Kept because the experiment is direct.
Supporting Evidence:
PMID:11085924
the overexpression of p114-Rho-GEF in J82 and HEK-293 cells induced the formation of actin stress fibres and stimulated serum-response-factor-mediated gene transcription in a Rho-dependent manner
GO:0030054 cell junction
TAS
Reactome:R-HSA-2160931
KEEP AS NON CORE
Summary: One of six identical Reactome cell-junction rows. ARHGEF18 is a component of Reactome's Tight Junction Complex entity, and every reaction that consumes or produces that complex assigns the cell-junction compartment to all of its participants. This reaction is Disassembly of tight junctions.
Reason: The underlying biology is well supported by direct experiment, so the row is not wrong, since ARHGEF18 really is a junctional protein. But the row is a participant-compartment assignment attached to a TGF-beta, PARD6A and SMURF1 reaction in which ARHGEF18 plays no described part, confirmed by querying the Reactome content service for the reaction's participants. Non-core also because GO:0030054 is the general parent of the informative term. Direct evidence supports the tight junction and apical junction complex specifically, and that is what the two proposed new compartment annotations record.
Supporting Evidence:
PMID:21258369
Junctional p114RhoGEF overlapped with occludin, a tight junction protein, but not E-cadherin, an adherens junction component, indicating that p114RhoGEF associates with the apical junctional complex and tight junctions
GO:0030054 cell junction
TAS
Reactome:R-HSA-2160932
KEEP AS NON CORE
Summary: One of six identical Reactome cell-junction rows, from the reaction SMURF1 binds phosphorylated PARD6A, whose inputs and outputs contain the Tight Junction Complex entity of which ARHGEF18 is a member.
Reason: Same participant-compartment mechanism and the same verdict as the other five Reactome cell-junction rows. Kept because junctional localisation is independently established by experiment; non-core because the term is general and the row carries no information specific to this gene.
GO:0030054 cell junction
TAS
Reactome:R-HSA-2160935
KEEP AS NON CORE
Summary: One of six identical Reactome cell-junction rows, from the reaction SMURF1 ubiquitinates RHOA within the tight-junction-associated complex.
Reason: Same participant-compartment mechanism and the same verdict. Worth one remark because RHOA appears here as the SMURF1 substrate rather than as the GEF's substrate, so the co-occurrence of ARHGEF18 and RHOA in this reaction is not evidence about exchange activity.
GO:0030054 cell junction
TAS
Reactome:R-NUL-2161147
KEEP AS NON CORE
Summary: One of six identical Reactome cell-junction rows. The R-NUL prefix marks an inferred, non-human-specific event, here TGFBR1 is recruited to tight junction by binding Pard6a.
Reason: Same participant-compartment mechanism as the R-HSA rows, one step further removed because the event itself is an inference rather than a human-curated reaction. Kept for the same reason and at the same level.
GO:0030054 cell junction
TAS
Reactome:R-NUL-2161160
KEEP AS NON CORE
Summary: One of six identical Reactome cell-junction rows, from the inferred event TGFBR2 is recruited to tight junctions-associated, Pard6a-bound, TGFBR1 after TGF-beta stimulation.
Reason: Same participant-compartment mechanism and the same verdict as the other five.
GO:0030054 cell junction
TAS
Reactome:R-NUL-2161165
KEEP AS NON CORE
Summary: One of six identical Reactome cell-junction rows, from the inferred event TGFBR2 phosphorylates Pard6a.
Reason: Same participant-compartment mechanism and the same verdict as the other five. Six rows asserting one fact, none of which is an observation about ARHGEF18.
GO:0031267 small GTPase binding
ISS
PMID:29876405
Crystal structures of the PH domains from Lbc family of RhoG...
NEW
Summary: Proposed new annotation, and the only molecular function of this protein that has been solved structurally. The PH domain of the mouse ortholog was crystallised at 1.4 angstrom bound to RhoA loaded with a GTP analogue, PDB 6BCB, and the same interface is a general property of the Lbc-family RhoGEFs, where it acts as a positive-feedback mechanism rather than as the catalytic site.
Reason: This is a distinct activity from the exchange reaction, on a different domain and in the opposite nucleotide state, and GO records none of it for this gene in any species. The transfer is by sequence similarity rather than IPI because the solved construct is the mouse ortholog UniProtKB:Q6P9R4; the ten RhoA-contacting residues computed from 6BCB at 4 angstrom map to human Ile-740, Arg-742, Glu-743, Val-744, Ala-745, Asn-746, Phe-752, Ile-754, Pro-761 and Met-763, all identical, so the interface is conserved without exception. GO:0031267 is the most specific term available, because GO:0017048 Rho GTPase binding was merged into it and it now has zero is_a children in both OLS4 and QuickGO, so neither the partner identity nor the GTP-loaded state can be expressed in the term itself. The reference field is deliberately the paper rather than GO_REF:0000024. That GO_REF covers manual transfer of experimentally-verified annotation data to orthologs, which presupposes an annotation on the donor, and the mouse record carries no GO:0031267 to transfer. Mouse Arhgef18 has 23 GO annotations and not one of them is experimental, ten being ISO projections from human. Citing PMID:29876405 directly keeps the row consistent with that fact, since the paper is where the similarity-bearing evidence actually lives. The cleaner two-step route, if MGI will take it, is to enter GO:0031267 on the mouse record first by IPI from this paper with RHOA in the WITH/FROM field, and let the human row follow as an ISS behind it.
Supporting Evidence:
PMID:29876405
Here we present two crystal structures at resolutions of 1.4 Å and 2.0 Å of RhoA complexed with the PH domain from p114RhoGEF (PDB access code 6BCB) and AKAP-LbcRhoGEF (PDB access code 6BCA), respectively
PMID:23493395
This demonstrates feasibility of the hypothesis that binding of activated RhoA to the PH domains acts as a positive feedback mechanism
file:human/ARHGEF18/ARHGEF18-bioinformatics/RESULTS.md
Bottom line: all ten RhoA-contacting residues of the mouse PH domain are identical in human ARHGEF18 and all ten lie inside the human PH domain (684-786), so the RhoA-binding interface is conserved without exception across the orthologs.
GO:0035023 regulation of Rho protein signal transduction
IBA
GO_REF:0000033
MODIFY
Summary: Phylogenetic propagation from PTN002677784, seeded by mouse Arhgef2 and human AKAP13. The conclusion is right but the term is sign-agnostic, and everything known about this protein says the sign is positive.
Reason: Every primary experiment on ARHGEF18 shows activation of Rho signalling, never inhibition. Purified protein catalyses exchange on RhoA; expressing it raises active RhoA and phosphorylated myosin light chain; depleting it lowers junctional active RhoA; and a patient missense allele in the DH domain reduces RHOA activation. UniProt already phrases the variant effect as decreased function in positive regulation of Rho protein signal transduction. GO:0035025 positive regulation of Rho protein signal transduction is current and non-obsolete in QuickGO, OLS4 and the GO API, and it is an is_a child of the term annotated here, so this is a straightforward refinement rather than a change of meaning. The refinement is warranted at clade level and not only from target data, which matters because an IBA encodes a judgment about the clade rather than about this gene. Both seeds are themselves exchange factors, mouse Arhgef2 being GEF-H1 and Q12802 being AKAP13/Lbc, and an exchange factor is by definition a positive regulator of its GTPase when active, so the ancestral call the node encodes already carries the positive sign; the target-specific results agree with it rather than substituting for it. Two further observations do not change the action. The seeds are paralogs rather than the target or its fly ortholog; and Terry et al. show that ARHGEF18 and GEF-H1 are functionally opposed at junctions, GEF-H1 being recruited and switched off where ARHGEF18 is recruited and switched on, which is a reason to be careful about transferring regulatory detail between them even though both positively regulate Rho when active.
Propagation Review
Root cause: TERM SCOPING PROBLEM
Failure modes: GRANULARITY MISMATCH
Sources checked:
PANTHER:PTN002677784 · PTHR47440 ancestral node, Lbc/RH-RhoGEF clade SUPPORTS TRANSFER
The clade-level inference is sound; only the sign-agnostic term is at issue.
MGI:MGI:103264 · mouse Arhgef2 (GEF-H1) SUPPORTS TRANSFER
A paralog, not the ortholog. Terry et al. show the two proteins are oppositely regulated at epithelial junctions.
UniProtKB:Q12802 · AKAP13 (Lbc) SUPPORTS TRANSFER
A paralog. Its PH domain binds activated RhoA in the same way this protein's does, in two structures from one study, PDB 6BCA and 6BCB.
Supporting Evidence:
PMID:28132693
the p.Thr270Ala missense variant affects a highly conserved residue in the DBL homology domain, which is required for the interaction and activation of RHOA
PMID:23698346
We show that ArhGEF18-mediated activation of the small GTPase RhoA is required to maintain apicobasal polarity at the onset of retinal differentiation and to control the ratio of neurogenic to proliferative cell divisions
GO:0043296 apical junction complex
IDA
PMID:21258369
Spatially restricted activation of RhoA signalling at epithe...
NEW
Summary: Proposed new annotation, from the same imaging that supports the tight junction row. Terry et al. state the conclusion in these terms, that p114RhoGEF associates with the apical junctional complex.
Reason: This is the compartment the mechanism is defined in. The protein is not simply at junctions, it is at the apical junctional complex, where it generates the spatially restricted pool of active RhoA that drives junctional myosin activation. GOA has nothing between GO:0016324 apical plasma membrane and GO:0030054 cell junction, and this term is exactly the intersection the evidence supports. Proposed alongside GO:0070160 rather than instead of it, and the two are genuinely complementary rather than one implying the other. That depended on the term choice and was checked, not assumed. GO:0005923 bicellular tight junction has GO:0043296 among its parents in both OLS4 and QuickGO, so had the tight-junction row been entered at that level this one would have been inferred by propagation up part_of; GO:0070160 tight junction has no such edge, its only hierarchical parent being GO:0005911 cell-cell junction.
Supporting Evidence:
PMID:21258369
Junctional p114RhoGEF overlapped with occludin, a tight junction protein, but not E-cadherin, an adherens junction component, indicating that p114RhoGEF associates with the apical junctional complex and tight junctions
GO:0045177 apical part of cell
IDA
PMID:22006950
Lulu2 regulates the circumferential actomyosin tensile syste...
KEEP AS NON CORE
Summary: The same Nakajima and Tanoue immunofluorescence that supports the apical plasma membrane row, curated by MGI at a more general term.
Reason: Correct but strictly less informative than GO:0016324 from the identical experiment, which is annotated separately as EXP. Kept because it is a direct observation and GOA legitimately carries both granularities; non-core because the specific term is the one that matters.
GO:0051497 negative regulation of stress fiber assembly
IMP
PMID:25753039
ZO-1 controls endothelial adherens junctions, cell-cell tens...
KEEP AS NON CORE
Summary: Depleting p114RhoGEF in human dermal microvascular endothelial cells induces stress fibres and vinculin-positive focal adhesions, so the protein is required to keep them down. The sign looks inverted for a RhoA activator, and the resolution is that the two observations are made in different systems.
Reason: The annotation is supported and reproducible. The same loss-of-function phenotype appears independently in epithelium, where Terry et al. report reduced perijunctional f-actin and increased formation of stress fibres. It is not in conflict with the gain-of-function result that overexpressed p114RhoGEF makes stress fibres in sparse J82 and HEK-293 cells, because confluence is the variable. Terry et al. state the mechanism directly, that RhoA activity is downregulated on confluence and interfering with junction formation stimulates RhoA signalling elsewhere in the cell. So this is a real but indirect effect, the cortical consequence of failing to build a junction rather than a molecular action on stress fibres, and involved_in slightly overstates the directness. Kept as non-core rather than modified, because no GO term expresses the causal shape, which is redistribution of a GTPase activity pool from the basal cortex to the junction.
Supporting Evidence:
PMID:25753039
p114RhoGEF depletion led to a loss of junctional vinculin and induction of vinculin-stained focal adhesions and stress fibers comparable to depletions of ZO-1 and JACOP
PMID:21258369
reduced perijunctional f-actin and increased formation of stress fibres
PMID:21258369
RhoA activity is downregulated in response to cell confluence; hence, interfering with junction formation stimulates RhoA signalling in the rest of the cell
GO:0070062 extracellular exosome
HDA
PMID:18570454
Proteomic analysis of exosomes from human neural stem cells ...
MARK AS OVER ANNOTATED
Summary: A single identification in a mass-spectrometry survey of exosomes from human neural stem cells, one of 66 proteins annotated from that paper.
Reason: ARHGEF18 is a 1361-residue cytoplasmic protein with no signal peptide and no transmembrane segment, whose characterised function requires it to be on the cytoplasmic face of a junction. A single bulk-proteomics identification in one cell type is the classic signature of co-purification with vesicle preparations rather than evidence of a secreted pool, and nothing in the twenty-odd primary papers on this gene reports an extracellular form. Marked as over-annotated rather than removed because the measurement itself was made and HDA is honest about what it is. The term is not contradicted; it is unsupported as a statement about where this protein does anything.
GO:0120192 tight junction assembly
IMP
PMID:21258369
Spatially restricted activation of RhoA signalling at epithe...
NEW
Summary: Proposed new annotation. Depleting p114RhoGEF leaves spreading and initial contact formation intact but blocks junctional maturation, so ZO-1 staining stays discontinuous, and transepithelial resistance reaches only 40 per cent of control while 4 and 70 kilodalton dextran continues to leak.
Reason: This is the process the gene is best characterised for and GOA does not record it at all. The experiment is a clean loss-of-function with a quantitative functional readout, and it is stage-resolved, since initial adhesion is unaffected and only maturation fails, which is what makes the assembly term rather than a maintenance term correct. It is corroborated in three further systems, bronchial epithelium through LKB1, endothelium through ZO-1 and paracingulin, and MDCK tubulogenesis where lumen consolidation specifically fails. The same paper supplies the two proposed compartment annotations, and it has produced no GO annotation in any species, which is the single largest curation gap on this gene.
Supporting Evidence:
PMID:21258369
Depletion of p114RhoGEF strongly attenuated barrier formation and only reached 40% of the values of control cultures
PMID:21258369
Thus, p114RhoGEF is not required for spreading and initiation of adhesion, but for junctional maturation.
PMID:23648482
Together, LKB1 and p114RhoGEF control RhoA activity in these cells to promote apical junction assembly
GO:0150105 protein localization to cell-cell junction
IMP
PMID:25753039
ZO-1 controls endothelial adherens junctions, cell-cell tens...
ACCEPT
Summary: Depleting p114RhoGEF in endothelial cells causes loss of junctional vinculin, and p114RhoGEF immunoprecipitates contain vinculin while ZO-1 immunoprecipitates do not. P18206 resolves to human vinculin.
Reason: The best-supported process annotation this gene has. It is specific, it names the cargo through the WITH/FROM field, and it is the process form of what the protein actually does, which is to organise the junctional cortex so that mechanotransducers are recruited. It generalises beyond vinculin and beyond endothelium, since ARHGEF18 depletion also disrupts junctional recruitment of myosin IIA in epithelium and of ZO-1 and other tight-junction markers, and since EPB41L5 and the Crumbs complex recruit it in podocytes and in Drosophila respectively. Accepted at core level.
Supporting Evidence:
PMID:25753039
p114RhoGEF depletion led to a loss of junctional vinculin and induction of vinculin-stained focal adhesions and stress fibers comparable to depletions of ZO-1 and JACOP
PMID:25753039
p114RhoGEF, and not ZO-1, immunoprecipitates contained vinculin

Core Functions

Guanine-nucleotide exchange factor that generates a spatially restricted pool of active RhoA at the apical junctional complex. The DH domain, whose conserved catalytic tyrosine is intact at Tyr-606, catalyses GDP release from RhoA; purified protein does this on RhoA and does not bind Rac1 or Cdc42, while in cells the protein has also been reported to load Rac1, and no source finds activity on Cdc42. The protein is not constitutively junctional. It is recruited there by a combinatorial set of adaptors that differs by tissue, cingulin in epithelium, ZO-1 and paracingulin in endothelium, EPB41L4B/Lulu2 with PATJ apically, CRB3A, LKB1, and EPB41L5 in podocytes, and its output is read out by a complex containing ROCK II and myosin IIA that it co-precipitates with. The functional consequence is myosin light-chain phosphorylation confined to the junction, which builds the circumferential actomyosin belt and matures tight junctions into a barrier. Because confluent cells globally downregulate RhoA, losing this protein does not lower Rho signalling overall, it moves it, so depleted cells simultaneously lose junctional actomyosin and gain basal stress fibres. The substrates listed are what the protein has been shown to act on, and the disagreement between them is unresolved rather than settled; the sequence analysis run here cannot arbitrate it.

Supporting Evidence:
  • PMID:11085924
    p114-Rho-GEF interacted specifically with RhoA, in its nucleotide-free and guanosine 5'-[gamma-thio]triphosphate-bound states, but not with Rac1 and Cdc42, and efficiently catalysed guanine nucleotide exchange of RhoA
  • PMID:14512443
    we have determined that p114RhoGEF activated RhoA and Rac1 but not Cdc42 proteins
  • PMID:21258369
    p114RhoGEF immunoprecipitates contained myosin IIA and the RhoA effector Rock II
  • PMID:21258369
    Depletion of p114RhoGEF strongly attenuated barrier formation and only reached 40% of the values of control cultures
  • PMID:22006950
    In its regulation of the belt, Lulu2 interacts with and activates p114RhoGEF, a Rho-specific guanine nucleotide exchanging factor (GEF), at apical cell-cell junctions
  • PMID:25753039
    p114RhoGEF and JACOP coimmunoprecipitated from endothelial cell extracts, and both ZO-1 and JACOP were required for junctional recruitment of p114RhoGEF
  • PMID:28536193
    by binding and recruiting the RhoGEF ARGHEF18 to the leading edge, EPB41L5 directly controls actomyosin contractility and subsequent maturation of focal adhesions, cell spreading, and migration
  • file:human/ARHGEF18/ARHGEF18-bioinformatics/RESULTS.md
    The substrate question is not settled by sequence.

A second, non-catalytic interaction with the same GTPase, on a different domain and in the opposite nucleotide state. The PH domain binds RhoA loaded with GTP, which the DH domain does not; the two sites are distinct, and the arrangement makes the protein a positive-feedback amplifier rather than a simple catalyst, so that RhoA already activated at a junction recruits and potentiates more exchange activity at the same site. This is the one part of ARHGEF18 that has been solved structurally, at 1.4 angstrom for the mouse PH domain bound to a GTP-analogue-loaded RhoA, and the entire RhoA-contacting surface is conserved in the human protein. The same interface is shared with the other Lbc-family RhoGEFs and is absent from Rac- and Cdc42-specific GEFs. It is the most plausible molecular explanation for how junctional RhoA activity stays spatially restricted instead of diffusing, and GO records none of it.

Supporting Evidence:
  • PMID:29876405
    Here we present two crystal structures at resolutions of 1.4 Å and 2.0 Å of RhoA complexed with the PH domain from p114RhoGEF (PDB access code 6BCB) and AKAP-LbcRhoGEF (PDB access code 6BCA), respectively
  • PMID:29876405
    All 7 Lbc RhoGEFs associate directly with activated Rho GTPases via their PH domains
  • PMID:23493395
    This demonstrates feasibility of the hypothesis that binding of activated RhoA to the PH domains acts as a positive feedback mechanism
  • file:human/ARHGEF18/ARHGEF18-bioinformatics/RESULTS.md
    Bottom line: all ten RhoA-contacting residues of the mouse PH domain are identical in human ARHGEF18 and all ten lie inside the human PH domain (684-786), so the RhoA-binding interface is conserved without exception across the orthologs.

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Does ARHGEF18 load Rac1 directly, or is the Rac1 activation seen in cells an indirect consequence of RhoA signalling or of GEF displacement?

Suggested experts: Tatyana Voyno-Yasenetskaya, G protein signalling to Rho GTPases and author of the paper reporting Rac1 activation, Mohammad Reza Ahmadian, quantitative nucleotide-exchange kinetics across the Dbl family

Q: The retinal phenotype is adult-onset and recessive while the medaka knockout is larval-lethal. Is the human disease a partial-function state, or is the retinal requirement genuinely later and more restricted in mammals?

Suggested experts: Karl Matter, junctional RhoA signalling and the ARHGEF18 retinal degeneration phenotype, Maria Balda, tight junction assembly and epithelial barrier formation

Q: SEPTIN9 inhibits SA-RhoGEF-dependent Rho activation in one study and activates ARHGEF18 in two later ones. Is the sign determined by the SEPTIN9 isoform, by the subcellular site, or by which region of ARHGEF18 is engaged?

Suggested experts: Masaki Inagaki, septin and RhoGEF interactions; identified SA-RhoGEF as a Sept9b partner, William Trimble, septin function at the ciliary base and in mitochondrial dynamics

Q: Should GO restore any means of recording GTPase substrate identity for exchange factors and activating proteins, given that the merge into GO:0005085 and GO:0005096 makes RhoA-directed, Rac-directed and Cdc42-directed regulators indistinguishable?

Suggested experts: GO Ontology Development Team, molecular function ontology structure and the rationale for the substrate merges

Suggested Experiments

Experiment: Measure nucleotide-exchange kinetics of the recombinant human ARHGEF18 DH-PH module on RhoA, RhoB, RhoC, RAC1 and CDC42 by stopped-flow using fluorescent nucleotide analogues, with a RhoA-specific GEF (LARG DH/PH) and a Rac1-specific GEF (TIAM1 DH/PH) run in parallel as positive controls and the Tyr-606 to alanine mutant as the negative control. This is the single experiment that would resolve the twenty-five-year-old disagreement between the two discovery papers, and it has never been done on this protein.

Experiment: Knock in the RP78 missense allele (canonical Thr-458 to alanine) at the endogenous locus in a polarised human epithelial or retinal organoid model and read out junctional active RhoA with a FRET biosensor alongside barrier function. The variant is reported as partial loss of function, so the informative measurement is how much junctional RhoA activity is lost rather than whether any is, and the same readouts distinguish a junction-assembly defect from a maintenance defect.

Experiment: Test whether the PH-domain RhoA-binding interface is required in cells by substituting the contact residues identified in PDB 6BCB (human Arg-742, Glu-743, Asn-746) and asking whether junctional RhoA activation, myosin light-chain phosphorylation and barrier formation still occur when the DH domain is intact. This separates catalysis from positive feedback, which no experiment on this protein has yet done.

Experiment: Determine which SEPTIN9 isoform and which ARHGEF18 region set the sign of the septin interaction, by reconstituting exchange assays with defined SEPTIN9 isoforms against full-length ARHGEF18 and against N-terminal and C-terminal truncations. The 2005 study mapped inhibition to the ARHGEF18 C-terminus binding the SEPTIN9 N-terminal variable region, while the 2023 and 2025 studies report activation through an N-terminal interaction, so the reagents to distinguish the two already exist.

Deep Research

Affinage

(ARHGEF18-deep-research-affinage.md)

Loading supporting content…

Download this section (compressed HTML)

📚 Additional Documentation

Notes

(ARHGEF18-notes.md)

Loading supporting content…

Download this section (compressed HTML)

Bioinformatics Results

(RESULTS.md)

Loading supporting content…

Download this section (compressed HTML)

📄 View Raw YAML

Loading supporting content…

Download this section (compressed HTML)